| Acquired by | Cadence Pharmaceuticals |
| Price | $285M |
| Date | 6/10 |
| Category | BioTech |
| Employees |
| TOTAL | $43M |
| VENTURE FUNDING TOTAL | $43M |
| Series A, 6/10 Frazier Healthcare Ventures 5AM Ventures Technology Partners Adams Street Partners Saints Capital Emergent Medical Partners | $43M |
Incline Therapeutics is a privately-held, hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). Incline is financed by leading life science venture capital firms and led by a management team with significant pharmaceutical and medical device industry experience. The company is based in Redwood City, California.
